{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T12:23:03Z","timestamp":1792930983791,"version":"4.5.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2019,11,22]],"date-time":"2019-11-22T00:00:00Z","timestamp":1574380800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,11,22]],"date-time":"2019-11-22T00:00:00Z","timestamp":1574380800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DK063922"],"award-info":[{"award-number":["DK063922"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"IBD Working Group"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1007\/s10620-019-05968-x","type":"journal-article","created":{"date-parts":[[2019,11,22]],"date-time":"2019-11-22T11:03:02Z","timestamp":1574420582000},"page":"2379-2387","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Opioid Analgesics Do Not Improve Abdominal Pain or Quality of Life in Crohn\u2019s Disease"],"prefix":"10.1007","volume":"65","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8976-5015","authenticated-orcid":false,"given":"M. D.","family":"Coates","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Seth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Abdul-Baki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Mahoney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Walter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. D.","family":"Regueiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Ramos-Rivers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I. E.","family":"Koutroubakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Bielefeldt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. G.","family":"Binion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,22]]},"reference":[{"key":"5968_CR1","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1136\/gut.24.3.190","volume":"24","author":"B Isgar","year":"1983","unstructured":"Isgar B, Harman M, Kaye MD, et al. Symptoms of irritable bowel syndrome in ulcerative colitis in remission. Gut. 1983;24:190\u2013192.","journal-title":"Gut"},{"key":"5968_CR2","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1023\/b:ddas.0000020506.84248.f9","volume":"49","author":"IM Minderhoud","year":"2004","unstructured":"Minderhoud IM, Oldenburg B, Wismeijer JA, et al. IBS-like symptoms in patients with inflammatory bowel disease in remission; relationships with quality of life and coping behavior. Dig Dis Sci. 2004;49:469\u2013474. https:\/\/doi.org\/10.1023\/b:ddas.0000020506.84248.f9.","journal-title":"Dig Dis Sci"},{"key":"5968_CR3","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/01.MIB.0000195391.49762.89","volume":"12","author":"F Farrokhyar","year":"2006","unstructured":"Farrokhyar F, Marshall JK, Easterbrook B, et al. Functional gastrointestinal disorders and mood disorders in patients with inactive inflammatory bowel disease: prevalence and impact on health. Inflamm Bowel Dis. 2006;12:38\u201346.","journal-title":"Inflamm Bowel Dis"},{"key":"5968_CR4","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1002\/ibd.20848","volume":"15","author":"K Bielefeldt","year":"2009","unstructured":"Bielefeldt K, Davis B, Binion DG. Pain and inflammatory bowel disease. Inflamm Bowel Dis. 2009;15:778\u2013788.","journal-title":"Inflamm Bowel Dis"},{"key":"5968_CR5","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1097\/MIB.0b013e31829614c6","volume":"19","author":"MD Coates","year":"2013","unstructured":"Coates MD, Lahoti M, Binion DG, et al. Abdominal pain in ulcerative colitis. Inflamm Bowel Dis. 2013;19:2207\u20132214.","journal-title":"Inflamm Bowel Dis"},{"key":"5968_CR6","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.3748\/wjg.v16.i25.3168","volume":"16","author":"A Schirbel","year":"2010","unstructured":"Schirbel A, Reichert A, Roll S, et al. Impact of pain on health-related quality of life in patients with inflammatory bowel disease. World J Gastroenterol. 2010;16:3168\u20133177.","journal-title":"World J Gastroenterol"},{"key":"5968_CR7","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1097\/MIB.0000000000001060","volume":"23","author":"WW IsHak","year":"2017","unstructured":"IsHak WW, Pan D, Steiner AJ, et al. Patient-reported outcomes of quality of life, functioning, and gi\/psychiatric symptom severity in patients with inflammatory bowel disease (IBD). Inflamm Bowel Dis. 2017;23:798\u2013803.","journal-title":"Inflamm Bowel Dis"},{"key":"5968_CR8","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.crohns.2013.11.019","volume":"8","author":"ME van der Valk","year":"2014","unstructured":"van der Valk ME, Mangen MJ, Leenders M, et al. Risk factors of work disability in patients with inflammatory bowel disease\u2014a Dutch nationwide web-based survey: work disability in inflammatory bowel disease. J Crohns Colitis. 2014;8:590\u2013597.","journal-title":"J Crohns Colitis"},{"key":"5968_CR9","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1097\/MIB.0000000000000962","volume":"22","author":"GA Tew","year":"2016","unstructured":"Tew GA, Jones K, Mikocka-Walus A. Physical activity habits, limitations, and predictors in people with inflammatory bowel disease: a large cross-sectional online survey. Inflamm Bowel Dis. 2016;22:2933\u20132942.","journal-title":"Inflamm Bowel Dis"},{"key":"5968_CR10","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1097\/00004836-199206000-00010","volume":"14","author":"AR Hay","year":"1992","unstructured":"Hay AR, Hay JW. Inflammatory bowel disease: medical cost algorithms. J Clin Gastroenterol. 1992;14:318\u2013327.","journal-title":"J Clin Gastroenterol"},{"key":"5968_CR11","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/ibd.21371","volume":"17","author":"MD Kappelman","year":"2011","unstructured":"Kappelman MD, Porter CQ, Galanko JA, et al. Utilization of healthcare resources by U.S. children and adults with inflammatory bowel disease. Inflamm Bowel Dis. 2011;17:62\u201368.","journal-title":"Inflamm Bowel Dis"},{"key":"5968_CR12","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1002\/ibd.22916","volume":"18","author":"JR Goodhand","year":"2012","unstructured":"Goodhand JR, Wahed M, Mawdsley JE, et al. Mood disorders in inflammatory bowel disease: relation to diagnosis, disease activity, perceived stress, and other factors. Inflamm Bowel Dis. 2012;18:2301\u20132309.","journal-title":"Inflamm Bowel Dis"},{"key":"5968_CR13","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/j.dld.2017.08.020","volume":"49","author":"W Chan","year":"2017","unstructured":"Chan W, Shim HH, Lim MS, et al. Symptoms of anxiety and depression are independently associated with inflammatory bowel disease-related disability. Dig Liver Dis. 2017;49:1314\u20131319.","journal-title":"Dig Liver Dis"},{"key":"5968_CR14","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1002\/ibd.20068","volume":"13","author":"HC Deter","year":"2007","unstructured":"Deter HC, Keller W, von Wietersheim J, et al. Psychological treatment may reduce the need for healthcare in patients with Crohn\u2019s disease. Inflamm Bowel Dis. 2007;13:745\u2013752.","journal-title":"Inflamm Bowel Dis"},{"key":"5968_CR15","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/apt.14108","volume":"46","author":"C Norton","year":"2017","unstructured":"Norton C, Czuber-Dochan W, Artom M, et al. Systematic review: interventions for abdominal pain management in inflammatory bowel disease. Aliment Pharmacol Ther. 2017;46:115\u2013125.","journal-title":"Aliment Pharmacol Ther"},{"issue":"430\u2013439","key":"5968_CR16","first-page":"e4","volume":"152","author":"M Regueiro","year":"2017","unstructured":"Regueiro M, Greer JB, Szigethy E. Etiology and treatment of pain and psychosocial issues in patients with inflammatory bowel diseases. Gastroenterology. 2017;152:e4.","journal-title":"Gastroenterology"},{"key":"5968_CR17","doi-asserted-by":"crossref","first-page":"350","DOI":"10.7326\/0003-4819-156-5-201203060-00007","volume":"156","author":"AN Ananthakrishnan","year":"2012","unstructured":"Ananthakrishnan AN, Higuchi LM, Huang ES, et al. Aspirin, nonsteroidal anti-inflammatory drug use, and risk for crohn disease and ulcerative colitis: a cohort study. Ann Intern Med. 2012;156:350\u2013359.","journal-title":"Ann Intern Med"},{"key":"5968_CR18","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1097\/MCG.0000000000000421","volume":"50","author":"MD Long","year":"2016","unstructured":"Long MD, Kappelman MD, Martin CF, et al. Role of nonsteroidal anti-inflammatory drugs in exacerbations of inflammatory bowel disease. J Clin Gastroenterol. 2016;50:152\u2013156.","journal-title":"J Clin Gastroenterol"},{"issue":"147\u2013159","key":"5968_CR19","first-page":"e15","volume":"10","author":"R Chou","year":"2009","unstructured":"Chou R, Ballantyne JC, Fanciullo GJ, et al. Research gaps on use of opioids for chronic noncancer pain: findings from a review of the evidence for an American Pain Society and American Academy of Pain Medicine clinical practice guideline. J Pain. 2009;10:e15.","journal-title":"J Pain"},{"key":"5968_CR20","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1097\/MIB.0000000000000194","volume":"20","author":"JA Crocker","year":"2014","unstructured":"Crocker JA, Yu H, Conaway M, et al. Narcotic use and misuse in Crohn\u2019s disease. Inflamm Bowel Dis. 2014;20:2234\u20132238.","journal-title":"Inflamm Bowel Dis"},{"key":"5968_CR21","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/j.cgh.2007.06.013","volume":"5","author":"DM Grunkemeier","year":"2007","unstructured":"Grunkemeier DM, Cassara JE, Dalton CB, et al. The narcotic bowel syndrome: clinical features, pathophysiology, and management. Clin Gastroenterol Hepatol. 2007;5:1126\u20131139. (quiz 1121-2).","journal-title":"Clin Gastroenterol Hepatol"},{"key":"5968_CR22","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1001\/jama.2011.370","volume":"305","author":"AB Bohnert","year":"2011","unstructured":"Bohnert AB, Valenstein M, Bair MJ, et al. ASsociation between opioid prescribing patterns and opioid overdose-related deaths. JAMA. 2011;305:1315\u20131321.","journal-title":"JAMA"},{"key":"5968_CR23","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1001\/jama.2016.7789","volume":"315","author":"WA Ray","year":"2016","unstructured":"Ray WA, Chung CP, Murray KT, et al. Prescription of long-acting opioids and mortality in patients with chronic noncancer pain. JAMA. 2016;315:2415\u20132423.","journal-title":"JAMA"},{"key":"5968_CR24","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.cgh.2006.03.002","volume":"4","author":"GR Lichtenstein","year":"2006","unstructured":"Lichtenstein GR, Feagan BG, Cohen RD, et al. Serious infections and mortality in association with therapies for Crohn\u2019s disease: TREAT Registry. Clin Gastroenterol Hepatol. 2006;4:621\u2013630.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"5968_CR25","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1002\/ibd.21806","volume":"18","author":"MD Long","year":"2012","unstructured":"Long MD, Barnes EL, Herfarth HH, et al. Narcotic use for inflammatory bowel disease and risk factors during hospitalization. Inflamm Bowel Dis. 2012;18:869\u2013876.","journal-title":"Inflamm Bowel Dis"},{"key":"5968_CR26","doi-asserted-by":"crossref","first-page":"182","DOI":"10.4103\/1319-3767.133020","volume":"20","author":"D Sanford","year":"2014","unstructured":"Sanford D, Thornley P, Teriaky A, et al. Opioid use is associated with decreased quality of life in patients with Crohn\u2019s disease. Saudi J Gastroenterol. 2014;20:182\u2013187.","journal-title":"Saudi J Gastroenterol"},{"key":"5968_CR27","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1093\/ibd\/izz100","volume":"25","author":"K Alley","year":"2019","unstructured":"Alley K, Singla A, Afzali A. Opioid use is associated with higher health care costs and emergency encounters in inflammatory bowel disease. Inflamm Bowel Dis. 2019;25:1990\u20131995.","journal-title":"Inflamm Bowel Dis"},{"issue":"534\u2013541","key":"5968_CR28","first-page":"e6","volume":"16","author":"NE Burr","year":"2018","unstructured":"Burr NE, Smith C, West R, et al. Increasing prescription of opiates and mortality in patients with inflammatory bowel diseases in England. Clin Gastroenterol Hepatol. 2018;16:e6.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"5968_CR29","doi-asserted-by":"publisher","first-page":"3236","DOI":"10.1007\/s10620-016-4278-z","volume":"61","author":"AJ Anderson","year":"2016","unstructured":"Anderson AJ, Click B, Ramos-Rivers C, et al. Development of an inflammatory bowel disease research registry derived from observational electronic health record data for comprehensive clinical phenotyping. Dig Dis Sci. 2016;61:3236\u20133245. https:\/\/doi.org\/10.1007\/s10620-016-4278-z.","journal-title":"Dig Dis Sci"},{"issue":"986\u201394","key":"5968_CR30","first-page":"e1","volume":"12","author":"C Ramos-Rivers","year":"2014","unstructured":"Ramos-Rivers C, Regueiro M, Vargas EJ, et al. Association between telephone activity and features of patients with inflammatory bowel disease. Clin Gastroenterol Hepatol. 2014;12:e1.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"5968_CR31","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.cgh.2011.05.016","volume":"9","author":"S Singh","year":"2011","unstructured":"Singh S, Blanchard A, Walker JR, et al. Common symptoms and stressors among individuals with inflammatory bowel diseases. Clin Gastroenterol Hepatol. 2011;9:769\u2013775.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"5968_CR32","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1097\/MIB.0b013e318280e729","volume":"19","author":"G Morrison","year":"2013","unstructured":"Morrison G, Van Langenberg D, Gibson S, et al. Chronic pain in inflammatory bowel disease: characteristics and associations of a hospital-based cohort. Inflamm Bowel Dis. 2013;19:1210\u20131217.","journal-title":"Inflamm Bowel Dis"},{"key":"5968_CR33","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1097\/MIB.0b013e3182802a0a","volume":"19","author":"L Zimmerman","year":"2013","unstructured":"Zimmerman L, Srinath A, Goyal A, et al. The overlap of functional abdominal pain in pediatric Crohn\u2019s disease. Inflamm Bowel Dis. 2013;19:826\u2013831.","journal-title":"Inflamm Bowel Dis"},{"key":"5968_CR34","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.1097\/01.MIB.0000435851.94391.37","volume":"19","author":"J Ravikoff Allegretti","year":"2013","unstructured":"Ravikoff Allegretti J, Courtwright A, Lucci M, et al. Marijuana use patterns among patients with inflammatory bowel disease. Inflamm Bowel Dis. 2013;19:2809\u20132814.","journal-title":"Inflamm Bowel Dis"},{"key":"5968_CR35","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1111\/j.1572-0241.2005.00256.x","volume":"100","author":"RK Cross","year":"2005","unstructured":"Cross RK, Wilson KT, Binion DG. Narcotic use in patients with Crohn\u2019s disease. Am J Gastroenterol. 2005;100:2225\u20132229.","journal-title":"Am J Gastroenterol"},{"key":"5968_CR36","doi-asserted-by":"publisher","first-page":"2799","DOI":"10.1007\/s10620-013-2719-5","volume":"58","author":"N Aggarwal","year":"2013","unstructured":"Aggarwal N, Bielefeldt K. Diagnostic stringency and healthcare needs in patients with biliary dyskinesia. Dig Dis Sci. 2013;58:2799\u20132808. https:\/\/doi.org\/10.1007\/s10620-013-2719-5.","journal-title":"Dig Dis Sci"},{"key":"5968_CR37","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1111\/liv.12215","volume":"33","author":"SS Rogal","year":"2013","unstructured":"Rogal SS, Winger D, Bielefeldt K, et al. Healthcare utilization in chronic liver disease: the importance of pain and prescription opioid use. Liver Int. 2013;33:1497\u20131503.","journal-title":"Liver Int"},{"key":"5968_CR38","doi-asserted-by":"crossref","first-page":"ES9","DOI":"10.36076\/ppj.2012\/15\/ES9","volume":"15","author":"L Manchikanti","year":"2012","unstructured":"Manchikanti L, Helm S, Fellows B, et al. Opioid epidemic in the United States. Pain Physician. 2012;15:ES9\u2013ES38.","journal-title":"Pain Physician"},{"key":"5968_CR39","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1097\/MLR.0b013e3182a95d86","volume":"51","author":"M Daubresse","year":"2013","unstructured":"Daubresse M, Chang HY, Yu Y, et al. Ambulatory diagnosis and treatment of nonmalignant pain in the united states, 2000\u20132010. Med Care. 2013;51:870\u2013878.","journal-title":"Med Care"},{"key":"5968_CR40","doi-asserted-by":"crossref","unstructured":"Zhong W, Maradit-Kremers H, St. Sauver JL, et al. Age and sex patterns of drug prescribing in a defined American population. Mayo Clinic Proc 2013;88:697-707","DOI":"10.1016\/j.mayocp.2013.04.021"},{"key":"5968_CR41","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1046\/j.1440-1746.2001.02468.x","volume":"16","author":"JT Edwards","year":"2001","unstructured":"Edwards JT, Radford-Smith GL, Florin TH. Chronic narcotic use in inflammatory bowel disease patients: prevalence and clinical characteristics. J Gastroenterol Hepatol. 2001;16:1235\u20131238.","journal-title":"J Gastroenterol Hepatol"},{"key":"5968_CR42","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1097\/MIB.0000000000001084","volume":"23","author":"N Narula","year":"2017","unstructured":"Narula N, Borges L, Steinhart AH, et al. Trends in narcotic and corticosteroid prescriptions in patients with inflammatory bowel disease in the United States ambulatory care setting from 2003 to 2011. Inflamm Bowel Dis. 2017;23:868\u2013874.","journal-title":"Inflamm Bowel Dis"},{"key":"5968_CR43","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/j.1526-4637.2007.00370.x","volume":"9","author":"DA Fishbain","year":"2008","unstructured":"Fishbain DA, Cole B, Lewis J, et al. What percentage of chronic nonmalignant pain patients exposed to chronic opioid analgesic therapy develop abuse\/addiction and\/or aberrant drug-related behaviors? A structured evidence-based review. Pain Med. 2008;9:444\u2013459.","journal-title":"Pain Med"},{"key":"5968_CR44","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/S1526-5900(03)00638-2","volume":"4","author":"J Breckenridge","year":"2003","unstructured":"Breckenridge J, Clark JD. Patient characteristics associated with opioid versus nonsteroidal anti-inflammatory drug management of chronic low back pain. J Pain. 2003;4:344\u2013350.","journal-title":"J Pain"},{"key":"5968_CR45","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/j.1360-0443.2007.02056.x","volume":"103","author":"JM Tetrault","year":"2008","unstructured":"Tetrault JM, Desai RA, Becker WC, et al. Gender and non-medical use of prescription opioids: results from a national US survey. Addiction. 2008;103:258\u2013268.","journal-title":"Addiction"},{"key":"5968_CR46","doi-asserted-by":"crossref","unstructured":"Becker WC, Sullivan LE, Tetrault JM, et al. Non-medical use, abuse and dependence on prescription opioids among U.S. adults: psychiatric, medical and substance use correlates. Drug and Alcohol Dependence 2008;94:38\u201347.","DOI":"10.1016\/j.drugalcdep.2007.09.018"},{"key":"5968_CR47","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.pharmthera.2009.12.005","volume":"126","author":"AA Izzo","year":"2010","unstructured":"Izzo AA, Sharkey KA. Cannabinoids and the gut: new developments and emerging concepts. Pharmacol Ther. 2010;126:21\u201338.","journal-title":"Pharmacol Ther"},{"key":"5968_CR48","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1743-3150.2004.00553.x","volume":"16","author":"C Sternini","year":"2004","unstructured":"Sternini C, Patierno S, Selmer IS, et al. The opioid system in the gastrointestinal tract. Neurogastroenterol Motil. 2004;16:3\u201316.","journal-title":"Neurogastroenterol Motil"},{"key":"5968_CR49","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.crohns.2013.02.004","volume":"7","author":"AM McCombie","year":"2013","unstructured":"McCombie AM, Mulder RT, Gearry RB. Psychotherapy for inflammatory bowel disease: a review and update. J Crohns Colitis. 2013;7:935\u2013949.","journal-title":"J Crohns Colitis"},{"key":"5968_CR50","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/nrgastro.2014.53","volume":"11","author":"JE Kurlander","year":"2014","unstructured":"Kurlander JE, Drossman DA. Diagnosis and treatment of narcotic bowel syndrome. Nat Rev Gastroenterol Hepatol. 2014;11:410\u2013418.","journal-title":"Nat Rev Gastroenterol Hepatol"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-019-05968-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-019-05968-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-019-05968-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,6]],"date-time":"2022-10-06T18:27:02Z","timestamp":1665080822000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-019-05968-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,22]]},"references-count":50,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["5968"],"URL":"https:\/\/doi.org\/10.1007\/s10620-019-05968-x","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,22]]},"assertion":[{"value":"31 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors of this manuscript have no relevant conflicts of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the University of Pittsburgh Institutional Review Board (IRB0309054) before data collection began. This study was undertaken in compliance with the principles and rules set forth by the United States Federal Policy on the Protection of Human Subjects.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}